CVS Health Corporation
CVS · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$2,800,000 | $1,021,000 | $1,779,000 | $1,623,000 |
| Dep. & Amort. | -$2,325,000 | $1,171,000 | $1,154,000 | $1,147,000 |
| Deferred Tax | $283,000 | -$114,000 | -$169,000 | $340,000 |
| Stock-Based Comp. | -$126,000 | $136,000 | $126,000 | $137,000 |
| Change in WC | -$1,571,000 | -$309,000 | $1,427,000 | -$394,000 |
| Other Non-Cash | $7,335,000 | -$8,000 | $239,000 | -$993,000 |
| Operating Cash Flow | $796,000 | $1,897,000 | $4,556,000 | $1,860,000 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$698,000 | -$607,000 | -$743,000 | -$768,000 |
| Net Acquisitions | $139,000 | -$119,000 | -$20,000 | -$10,000 |
| Inv. Purchases | -$3,859,000 | -$3,634,000 | -$3,552,000 | -$2,514,000 |
| Inv. Sales/Matur. | $2,774,000 | $3,332,000 | $3,534,000 | $2,719,000 |
| Other Inv. Act. | -$443,000 | $4,000 | $19,000 | $26,000 |
| Investing Cash Flow | -$2,087,000 | -$1,024,000 | -$762,000 | -$547,000 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$671,000 | $1,761,000 | -$1,602,000 | $1,206,000 |
| Stock Issued | $117,000 | $47,000 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | -$846,000 | -$866,000 | -$840,000 | -$838,000 |
| Other Fin. Act. | $18,000 | -$136,000 | $110,000 | $63,000 |
| Financing Cash Flow | -$1,382,000 | $806,000 | -$2,332,000 | $431,000 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$2,673,000 | $1,679,000 | $1,462,000 | $1,744,000 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $12,025,000 | $10,346,000 | $8,884,000 | $7,140,000 |
| End Cash | $9,352,000 | $12,025,000 | $10,346,000 | $8,884,000 |
| Free Cash Flow | $98,000 | $1,290,000 | $3,813,000 | $1,092,000 |